In contrast, little association between BDNF and depressive symptom improvement was found in a meta-analysis examining treatment-resistant depression patients receiving a wide range of treatments, including ECT, rTMS, VNS, ketamine, lamotrigine, riluzole, and atypical antipsychotics [21]. Here, BDNF is linked to depressive symptom measurement.